Assessing the landscape of STXBP1 -related disorders in 534 individuals
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
Disease-causing variants in STXBP1 are among the most common genetic causes of neurodevelopmental disorders. However, the phenotypic spectrum in STXBP1-related disorders is wide and clear correlations between variant type and clinical features have not been observed so far. Here, we harmonized clinical data across 534 individuals with STXBP1-related disorders and analysed 19 973 derived phenotypic terms, including phenotypes of 253 individuals previously unreported in the scientific literature. The overall phenotypic landscape in STXBP1-related disorders is characterized by neurodevelopmental abnormalities in 95% and seizures in 89% of individuals, including focal-onset seizures as the most common seizure type (47%). More than 88% of individuals with STXBP1-related disorders have seizure onset in the first year of life, including neonatal seizure onset in 47%. Individuals with protein-truncating variants and deletions in STXBP1 (n = 261) were almost twice as likely to present with West syndrome and were more phenotypically similar than expected by chance. Five genetic hotspots with recurrent variants were identified in more than 10 individuals, including p.Arg406Cys/His (n = 40), p.Arg292Cys/His/Leu/Pro (n = 30), p.Arg551Cys/Gly/His/Leu (n = 24), p.Pro139Leu (n = 12), and p.Arg190Trp (n = 11). None of the recurrent variants were significantly associated with distinct electroclinical syndromes, single phenotypic features, or showed overall clinical similarity, indicating that the baseline variability in STXBP1-related disorders is too high for discrete phenotypic subgroups to emerge. We then reconstructed the seizure history in 62 individuals with STXBP1-related disorders in detail, retrospectively assigning seizure type and seizure frequency monthly across 4433 time intervals, and retrieved 251 anti-seizure medication prescriptions from the electronic medical records. We demonstrate a dynamic pattern of seizure control and complex interplay with response to specific medications particularly in the first year of life when seizures in STXBP1-related disorders are the most prominent. Adrenocorticotropic hormone and phenobarbital were more likely to initially reduce seizure frequency in infantile spasms and focal seizures compared to other treatment options, while the ketogenic diet was most effective in maintaining seizure freedom. In summary, we demonstrate how the multidimensional spectrum of phenotypic features in STXBP1-related disorders can be assessed using a computational phenotype framework to facilitate the development of future precision-medicine approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Membrane Fusion: Grappling with SNARE and SM Proteins
Südhof, T. C., & Rothman, J. E. (2009) · Science · doi:10.1126/science.1161748 · Cited by 2,027 · cited 1×
“Munc18-1 is a key organizer of the neuronal SNARE complex, the molecular machine driving synaptic vesicle fusion.(9,10) Homozygous Munc18 knockout mice have no synaptic transmission, emphasizing the crucial role of Sec1/Munc18 in the presynapse.”
Synaptic Assembly of the Brain in the Absence of Neurotransmitter Secretion
Verhage, M., Maia, A. S., Plomp, J. J., Brussaard, A. B., Heeroma, J. H., Vermeer, H., Toonen, R. F., Hammer, R. E., van den, T. K., Berg, et al. (2000) · Science · doi:10.1126/science.287.5454.864 · Cited by 1,428 · cited 1×
“Homozygous Munc18 knockout mice have no synaptic transmission, emphasizing the crucial role of Sec1/Munc18 in the presynapse.(11) In addition, the role of STXBP1 has been recognized in the Golgi complex and intracellular trafficking.”
Self-citationThe Human Phenotype Ontology in 2021
Köhler, S., Gargano, M., Matentzoglu, N., Carmody, L. C., Lewis-Smith, D., Vasilevsky, N. A., Danis, D., Balagura, G., Baynam, G., Brower, A. M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1043 · Cited by 1,138 · cited 1×
“The Human Phenotype Ontology (HPO) is emerging as the lingua franca in the field and is widely used in clinical laboratory and research settings.(29,30) Large studies such as the Deciphering Developmental Disorders study, the UK Biobank, and prominent molecular diagnostic laboratories use HPO, and we have previously s…”
Self-citationThe human phenotype ontology: a tool for annotating and analyzing human hereditary disease
Robinson, P. N., Köhler, S., Bauer, S., Seelow, D., Horn, D., & Mundlos, S. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.017 · Cited by 1,034 · cited 1×
“The Human Phenotype Ontology (HPO) is emerging as the lingua franca in the field and is widely used in clinical laboratory and research settings.(29,30) Large studies such as the Deciphering Developmental Disorders study, the UK Biobank, and prominent molecular diagnostic laboratories use HPO, and we have previously s…”
Molecular machines governing exocytosis of synaptic vesicles
Jahn, R., & Fasshauer, D. (2012) · Nature · doi:10.1038/nature11320 · Cited by 970 · cited 1×
“Munc18-1 is a key organizer of the neuronal SNARE complex, the molecular machine driving synaptic vesicle fusion.(9,10) Homozygous Munc18 knockout mice have no synaptic transmission, emphasizing the crucial role of Sec1/Munc18 in the presynapse.”
Saitsu, H., Kato, M., Mizuguchi, T., Hamada, K., Osaka, H., Tohyama, J., Uruno, K., Kumada, S., Nishiyama, K., Nishimura, A., et al. (2008) · Nature Genetics · doi:10.1038/ng.150 · Cited by 556
Lux, A. L., Edwards, S. W., Hancock, E., Johnson, A. L., Kennedy, C. R., Newton, R. W., O'Callaghan, F. J., Verity, C. M., & Osborne, J. P. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70199-x · Cited by 405
STXBP1 encephalopathy: A neurodevelopmental disorder including epilepsy
Stamberger, H., Nikanorova, M., Willemsen, M. H., Accorsi, P., Angriman, M., Baier, H., Benkel-Herrenbrueck, I., Benoit, V., Budetta, M., Caliebe, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002457 · Cited by 317
Self-citationClassification, Ontology, and Precision Medicine
Haendel, M. A., Chute, C. G., & Robinson, P. N. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1615014 · Cited by 317 · cited 1×
“Methods based on controlled vocabularies and bio-ontologies allow for heterogeneous clinical data to be harmonized across a wide range of sources.(28) The Human Phenotype Ontology (HPO) is emerging as the lingua franca in the field and is widely used in clinical laboratory and research settings.”
Efficacy of the Ketogenic Diet as a Treatment Option for Epilepsy: Meta-analysis
Henderson, C. B., Filloux, F. M., Alder, S. C., Lyon, J. L., & Caplin, D. A. (2006) · Journal of Child Neurology · doi:10.2310/7010.2006.00044 · Cited by 264 · cited 1×
“one use for seizure treatment, performed according to the United Kingdom Infantile Spasms Study (UKISS) at our institution,(37) and the ketogenic diet.(38) Excluding rescue medications, we compared”
GABRA1 and STXBP1 : Novel genetic causes of Dravet syndrome
Carvill, G. L., Weckhuysen, S., McMahon, J. M., Hartmann, C., Møller, R. S., Hjalgrim, H., Cook, J., Geraghty, E., O’Roak, B. J., Petrou, S., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000291 · Cited by 260
Self-citationMutations in STX1B, encoding a presynaptic protein, cause fever-associated epilepsy syndromes
EuroEPINOMICS RES Consortium, Schubert, J., Siekierska, A., Langlois, M., May, P., Huneau, C., Becker, F., Muhle, H., Suls, A., Lemke, J. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.3130 · Cited by 193
Self-citationSodium channelopathies in neurodevelopmental disorders
Meisler, M. H., Hill, S. F., & Yu, W. (2021) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-00418-4 · Cited by 192
Identification of novel genetic causes of Rett syndrome-like phenotypes
Lopes, F., Barbosa, M., Ameur, A., Soares, G., de Sá, J., Dias, A. I., Oliveira, G., Cabral, P., Temudo, T., Calado, E., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103568 · Cited by 186
López-Rivera, J. A., Pérez‐Palma, E., Symonds, J. D., Lindy, A. S., McKnight, D., Leu, C., Zuberi, S. M., Brunklaus, A., Møller, R. S., & Lal, D. (2020) · Brain · doi:10.1093/brain/awaa051 · Cited by 171 · cited 1×
“Disease-causing alterations in STXBP1 are among the most common causes of neurodevelopmental disorders and epilepsy with an estimated frequency of at least 1:30 000.(1,2) The role of STXBP1 variants in human neurological disorders was initially identified in Ohtahara syndrome,(3) but subsequent studies have identified…”
Self-citationClinical spectrum of early-onset epileptic encephalopathies associated with STXBP1 mutations
Deprez, L., Weckhuysen, S., Holmgren, P., Suls, A., Van Dyck, T., Goossens, D., Del-Favero, J., Jansen, A., Verhaert, K., Lagae, L., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181f4d7bf · Cited by 166
Self-citationSalpietro, V., Malintan, N. T., Llano-Rivas, I., Spaeth, C. G., Efthymiou, S., Striano, P., Vandrovcova, J., Cutrupi, M. C., Chimenz, R., David, E., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.02.016 · Cited by 134
Self-citationKovačević, J., Maroteaux, G., Schut, D., Loos, M., Dubey, M., Pitsch, J., Remmelink, E., Koopmans, B., Crowley, J., Cornelisse, L. N., et al. (2018) · Brain · doi:10.1093/brain/awy046 · Cited by 132 · cited 1×
“The main disease mechanism in STXBP1-related disorders is haploinsufficiency.(14) However, possible dominant-negative effects(15) and gain-of-function effects(16) have also been suggested.”
Self-citationMilh, M., Villeneuve, N., Chouchane, M., Kaminska, A., Laroche, C., Barthez, M. A., Gitiaux, C., Bartoli, C., Borges-Correia, A., Cacciagli, P., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03181.x · Cited by 126
SNAREopathies: Diversity in Mechanisms and Symptoms
Verhage, M., & Sørensen, J. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.05.036 · Cited by 121 · cited 1×
“STXBP1 encodes the syntaxin-binding protein 1, Sec1/Munc18-1, a synaptic vesicle protein involved in vesicle release.(8) Munc18-1 is a key organizer of the neuronal SNARE complex, the molecular machine driving synaptic vesicle fusion.”
Self-citationHelbig, I., Lopez-Hernandez, T., Shor, O., Galer, P., Ganesan, S., Pendziwiat, M., Rademacher, A., Ellis, C. A., Hümpfer, N., Schwarz, N., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.04.001 · Cited by 119
Self-citationSTXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies
Abramov, D., Guiberson, N. G. L., & Burré, J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15120 · Cited by 114 · cited 1×
“In addition, the role of STXBP1 has been recognized in the Golgi complex and intracellular trafficking.(12,13) The main disease mechanism in STXBP1-related disorders is haploinsufficiency.”
Otsuka, M., Oguni, H., Liang, J., Ikeda, H., Imai, K., Hirasawa, K., Imai, K., Tachikawa, E., Shimojima, K., Osawa, M., et al. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02767.x · Cited by 113
DNM1 encephalopathy: A new disease of vesicle fission
von Spiczak, S., Helbig, K. L., Shinde, D. N., Huether, R., Pendziwiat, M., Lourenço, C., Nunes, M. E., Sarco, D. P., Kaplan, R. A., Dlugos, D. J., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004152 · Cited by 113
Self-citationVögtle, F. ‐., Brändl, B., Larson, A. A., Pendziwiat, M., Friederich, M. W., White, S. M., Basinger, A., Küçükköse, C., Muhle, H., Jähn, J. A., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.02.014 · Cited by 102
Self-citationMechanism-based rescue of Munc18-1 dysfunction in varied encephalopathies by chemical chaperones
Guiberson, N. G. L., Pineda, A., Abramov, D., Kharel, P., Carnazza, K. E., Wragg, R. T., Dittman, J. S., & Burré, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06507-4 · Cited by 91 · cited 2×
“Some of these strategies, such as pharmacological chaperones for protein stabilization, are expected to be assessed in clinical trials soon.(15) Analysis of clinical features linked to neurodevelopmental disorders has previously been performed in a non-standardized way, using a variety of templates and case-report for…”
Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission
Lammertse, H. C. A., van Berkel, A. A., Iacomino, M., Toonen, R. F. G., Striano, P., Gambardella, A., Verhage, M., & Zara, F. (2019) · Brain · doi:10.1093/brain/awz391 · Cited by 69
Self-citationGrinspan, Z. M., Patel, A. D., Shellhaas, R. A., Berg, A. T., Axeen, E. T., Bolton, J. B., Clarke, D. F., Coryell, J. C., Gaillard, W. D., Goodkin, H. P., et al. (2020) · Epilepsia · doi:10.1111/epi.16733 · Cited by 65
Self-citationComputational analysis of 10,860 phenotypic annotations in individuals with SCN2A-related disorders
Crawford, K., Xian, J., Helbig, K. L., Galer, P. D., Parthasarathy, S., Lewis‐Smith, D., Kaufman, M. C., Fitch, E., Ganesan, S., O’Brien, M., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-021-01120-1 · Cited by 63 · cited 3×
“Conversely, when assessing recurrent variants and hotspots, none of the major recurrent variants in STXBP1 had significant phenotypic similarity, in contrast to main recurrent variants in other neurodevelopmental disorders such as SCN2A-related disorders.(32) This suggests that despite observed trends of recurrent var…”
Self-citationPersonalized medicine in genetic epilepsies – possibilities, challenges, and new frontiers
Helbig, I., & Ellis, C. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.107970 · Cited by 53
Self-citationDe novo variants in SNAP25 cause an early-onset developmental and epileptic encephalopathy
Klöckner, C., Sticht, H., Zacher, P., Popp, B., Babcock, H. E., Bakker, D. P., Barwick, K., Bonfert, M. V., Bönnemann, C. G., Brilstra, E. H., et al. (2021) · Genetics in Medicine · doi:10.1038/s41436-020-01020-w · Cited by 47
Self-citationSTXBP1-associated neurodevelopmental disorder: a comparative study of behavioural characteristics
Study, T. D., O’Brien, S., Ng‐Cordell, E., Astle, D. E., Scerif, G., & Baker, K. (2019) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-019-9278-9 · Cited by 43
Self-citationGaler, P. D., Ganesan, S., Lewis‐Smith, D., Ruggiero, S. M., Pendziwiat, M., Helbig, K. L., Ellis, C. A., Rademacher, A., Smith, L. A., Poduri, A., et al. (2020) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2020.08.003 · Cited by 41 · cited 3×
“nition can be replicated through computational algorithms, referred to as semantic similarity algorithms.(31) These methods are”
Self-citationProtein structure and phenotypic analysis of pathogenic and population missense variants in STXBP1
Suri, M., Evers, J. M. G., Laskowski, R. A., O’Brien, S., Baker, K., Clayton‐Smith, J., Dabir, T. A., Josifova, D. J., Joss, S. K., Kerr, B. A., et al. (2017) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.304 · Cited by 36 · cited 1×
“The role of STXBP1 variants in human neurological disorders was initially identified in Ohtahara syndrome,(3) but subsequent studies have identified a broader range of other neurological features.(2,4,5) However, in contrast to other genetic causes of neurodevelopmental disorders,(6,7) STXBP1-related disorders have re…”
Self-citationGanesan, S., Galer, P. D., Helbig, K. L., Ruggiero, S. M., O’Brien, M., Gonzalez, A. K., Felmeister, A. S., Khankhanian, P., Ellis, C. A., & Helbig, I. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0923-1 · Cited by 36 · cited 3×
“Reconstruction of anti-seizure medications using a hybrid approach of EMR data extraction and manual review We extracted prescriptions for the most common anti-seizure medications (ASM) from the electronic medical records (EMRs) at Children’s Hospital of Philadelphia.34 In several individuals with adrenocorticotropic…”
InfluentialSelf-citationSTXBP1 encephalopathy is associated with awake bruxism
Rezazadeh, A., Uddin, M. J., Snead, O. C., Lira, V., Silberberg, A., Weiss, S. K., Donner, E. J., Zak, M., Bradbury, L., Scherer, S. W., et al. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.12.018 · Cited by 24
Targeted stabilization of Munc18‐1 function via pharmacological chaperones
Abramov, D., Guiberson, N. G. L., Daab, A., Na, Y., Petsko, G. A., Sharma, M., & Burré, J. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202012354 · Cited by 24
Ganesan, S., Galer, P. D., Helbig, K. L., Ruggiero, S. M., O’Brien, M., Gonzalez, A. K., Felmeister, A. S., Khankhanian, P., Ellis, C. A., & Helbig, I. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-00953-6 · Cited by 21
Self-citationLoss of MUNC18‐1 leads to retrograde transport defects in neurons
van Berkel, A. A., Santos, T. C., Shaweis, H., van Weering, J. R. T., Toonen, R. F. G., & Verhage, M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15256 · Cited by 14 · cited 1×
“In addition, the role of STXBP1 has been recognized in the Golgi complex and intracellular trafficking.(12,13) The main disease mechanism in STXBP1-related disorders is haploinsufficiency.”
Self-citation
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
“‘SNAREopathies’ 99 cause DEEs, often accompanied by movement disorders 100–104 , due to pathogenic variants in genes including STXBP1 , SNAP2 , VAMP2 , DNM1 and CPLX1 , disrupting the presynaptic complex (Supplementary Table 1).”
The current landscape of epilepsy genetics: where are we, and where are we going?
Ruggiero, S. M., Xian, J., & Helbig, I. (2023) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001141 · Cited by 82
Self-citationAuvin, S., Arzimanoglou, A. A., Falip, M., Striano, P., & Cross, J. H. (2024) · Epilepsia Open · doi:10.1002/epi4.13075 · Cited by 55
Self-citationEpilepsy Course and Developmental Trajectories in STXBP1 -DEE
Balagura, G., Xian, J., Riva, A., Marchese, F., Zeev, B. B., Ríos, L., Sirsi, D., Accorsi, P., Amadori, E., Astrea, G., et al. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000000676 · Cited by 52
“A recent study used a computational framework to analyze the phenotypic landscape of >500 individuals with STXBP1related disorders, being the most extensive analysis to date.(31) The study shows that protein-truncating variants and deletions in STXBP1 were more phenotypically similar compared with missense variants; f…”
Self-citationDelineating clinical and developmental outcomes in STXBP1-related disorders
Xian, J., Thalwitzer, K. M., McKee, J. L., Sullivan, K. R., Brimble, E., Fitch, E., Toib, J., Kaufman, M. C., deCampo, D., Cunningham, K. G., et al. (2023) · Brain · doi:10.1093/brain/awad287 · Cited by 49
“As previously recognized, 3 we found that epilepsy histories di-verge between individuals with missense variants compared to PTV and deletions.”
InfluentialSelf-citation
Metadata
- Authors
- Xian, J., Parthasarathy, S., Ruggiero, S. M., Balagura, G., Fitch, E., Helbig, K., Gan, J., Ganesan, S., Kaufman, M. C., Ellis, C. A., Lewis-Smith, D., Galer, P., Cunningham, K., O’Brien, M., Cosico, M., Baker, K., Darling, A., Veiga de Goes, F., El Achkar, C. M., Doering, J. H., Furia, F., García-Cazorla, Á., Gardella, E., Geertjens, L., Klein, C., Kolesnik-Taylor, A., Lammertse, H., Lee, J., Mackie, A., Misra-Isrie, M., Olson, H., Sexton, E., Sheidley, B., Smith, L., Sotero, L., Stamberger, H., Syrbe, S., Thalwitzer, K. M., van Berkel, A., van Haelst, M., Yuskaitis, C., Weckhuysen, S., Prosser, B., Son Rigby, C., Demarest, S., Pierce, S., Zhang, Y., Møller, R. S., Bruining, H., Poduri, A., Zara, F., Verhage, M., Striano, P., & Helbig, I.
- Affiliations
- Children's Hospital of Philadelphia (US)
- Istituto Giannina Gaslini (IT)
- Sichuan University (CN)
- Translational and Clinical Research Institute, Newcastle University , Newcastle-upon-Tyne NE2 4HH, UK
- MRC Cognition and Brain Sciences Unit (GB)
- Hospital Sant Joan de Déu Barcelona (ES)
- Department of Pediatrics and Pediatric Neurology Laboratory, Instituto Fernandes Figueira , Rio de Janeiro 22250-020, Brazil
- Division of Epilepsy and Clinical Neurophysiology and Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital , Boston, MA, USA
- University Hospital Heidelberg (DE)
- Filadelfia (DK)
- Pediatric Neurology Department, Hospital Sant Joan de Déu, University of Barcelona , Barcelona, Spain
- Amsterdam University Medical Centers (NL)
- Children's Hospital Colorado (US)
- MRC Cognition and Brain Sciences Unit, University of Cambridge , Cambridge, UK
- Samsung Medical Center (KR)
- Department of Human Genetics, Center for Neurogenomics and Cognitive Research (CNCR), Amsterdam University Medical Center , de Boelelaan 1085, 1081 HV Amsterdam, The Netherlands
- Boston Children's Hospital (US)
- Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (BR)
- Antwerp University Hospital (BE)
- Department of Functional Genomics, Center for Neurogenomics and Cognitive Research (CNCR), VU University Amsterdam , De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands
- University of Antwerp (BE)
- Department of Physiology, University of Pennsylvania Perelman School of Medicine , Philadelphia, PA 19104, USA
- STXBP1 Foundation , Apex, NC 27539, USA
- Peking University (CN)
- Corresponding author
- Helbig, Ingo
- ORCID
- Xian, Julie
- Parthasarathy, Shridhar
- Ruggiero, Sarah M
- Balagura, Ganna
- Helbig, Katherine
- Gan, Jing
- Ganesan, Shiva
- Kaufman, Michael C
- Ellis, Colin A
- Lewis-Smith, David
- Galer, Peter
- Cunningham, Kristin
- Cosico, Mahgenn
- Baker, Kate
- Darling, Alejandra
- Furia, Francesca
- Gardella, Elena
- Geertjens, Lisa
- Lammertse, Hanna
- Lee, Jeehun
- Olson, Heather
- Sexton, Emma
- Sheidley, Beth
- Smith, Lacey
- Stamberger, Hannah
- Syrbe, Steffen
- Thalwitzer, Kim Marie
- Yuskaitis, Christopher
- Weckhuysen, Sarah
- Demarest, Scott
- Pierce, Samuel
- Zhang, Yuehua
- Møller, Rikke S
- Bruining, Hilgo
- Poduri, Annapurna
- Zara, Federico
- Verhage, Matthijs
- Striano, Pasquale
- Helbig, Ingo
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2021-11-23
- Volume
- 145
- Issue
- 5
- Pages
- 1668-1683
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC9166568
- OpenAlex
- W4206071515
- Cited by
- 130
- References
- 40
- Citations by year
- 2026: 28 · 2025: 30 · 2024: 39 · 2023: 18 · 2022: 15
- FWCI
- 12.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- VU Research Portal (publishedVersion, other-oa)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- Children's Hospital of Philadelphia (UL1TR001878, HD086984, U54 HD086984)
- Hartwell Foundation
- University of Pennsylvania (UL1 TR001878, U54HD086984)
- Institute for Translational Medicine and Therapeutics (UL1TR001878)
- Wellcome Trust (203914/Z/16/Z)
- European Science Foundation (HE5415/3‐1, HE5415/5-1, HE5415/6-1)
- Great Ormond Street Hospital Charity
- Deutsche Forschungsgemeinschaft (We4896/4-570 1, FOR‐2715, 2018-2022, HE 5415/6-1, HE5415/5‐1, HE5415/7-1, WE4896/3-1, HE5415/3-1, We4896/4-570, INTER/DFG/17/11583046)
- Fonds Wetenschappelijk Onderzoek
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (024.004.012, NWO 024.004.012)
- Ministero dell’Istruzione, dell’Università e della Ricerca (20182022, legge 232 del 2016, MIUR 2018-2022)
- National Institutes of Health (2018-2022, HD086984, UL1TR001878)
- Intellectual and Developmental Disabilities Research Center (U54 HD086984)
- Perelman School of Medicine, University of Pennsylvania (MDBR-20-136-STXBP1, UL1TR001878)
- Medical Research Council (MC_UU_00030/3, G101400)
- National Institute of Neurological Disorders and Stroke (K23NS107646, K02NS112600, T32NS091008, U24NS120854, K23NS121520)
- National Institute of Child Health and Human Development
- National Center for Advancing Translational Sciences
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD086984, P50HD105351)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- STXBP1, neurodevelopmental disorders, phenotypic spectrum, seizures, infantile spasms, West syndrome, focal seizures, truncating mutations, recurrent variants, seizure history, seizure control, antiepileptic drugs, ketogenic diet, phenobarbital, ACTH, seizure onset
- MeSH terms
- Electroencephalography, Epilepsy, Humans, Infant, Retrospective Studies, Seizures, Spasms, Infantile, Munc18 Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.